Here: a quiz about treating oral candidiasis with an azole drug in an HIV-positive person.
When oral candidiasis develops in a person with HIV infection, therapy with an azole drug will be most effective if the underlying pathogen is:
FDA Accepts Protocol for Annovis Bio’s Buntanetap Phase 3 Alzheimer Disease Trial
January 9th 2025Buntanetap is an oral molecule designed to inhibit the production of multiple neurotoxic proteins and is under investigation for treatment of Alzheimer Disease, Parkinson’s Disease, and other neurodegenerative diseases.